Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citius Pharmaceuticals: Q1 Earnings Insights

Citius Pharmaceuticals (NASDAQ:CTXR) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Citius Pharmaceuticals reported in-line EPS of $-0.06 versus an estimate of $-0.06.
byBenzinga Insights
February 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citius Pharmaceuticals (NASDAQ:CTXR) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Citius Pharmaceuticals reported in-line EPS of $-0.06 versus an estimate of $-0.06.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01, which was followed by a 5.88% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Avantor

By Benzinga Insights
Today, 5:56 PM
Avantor (NYSE:AVTR) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement. Analysts estimate that Avantor will likely report an Earnings Per Share (EPS) of $0.32

AVTR